Published by Josh White on 12th November 2024
(Sharecast News) - AstraZeneca upgraded its full-year revenue and earnings per share guidance on Tuesday, citing strong growth across key therapy areas and robust financial results for the first nine months of the year.
URL: http://www.digitallook.com/dl/news/story/34683732/...